Dimenoxadol

Source: Wikipedia, the free encyclopedia.
Dimenoxadol
Clinical data
Other namesDimenoxadol, Estocin
ATC code
  • none
Legal status
Legal status
Identifiers
  • 2-(dimethylamino)ethyl 2-ethoxy-2,2-diphenylacetate
JSmol)
  • CCOC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(C)C
  • InChI=1S/C20H25NO3/c1-4-24-20(17-11-7-5-8-12-17,18-13-9-6-10-14-18)19(22)23-16-15-21(2)3/h5-14H,4,15-16H2,1-3H3 checkY
  • Key:RHUWRJWFHUKVED-UHFFFAOYSA-N checkY
  (verify)

Dimenoxadol (

INN) (brand name Estocin (in Russia)), or dimenoxadole (BAN), is an opioid analgesic which is a benzilic acid derivative, closely related to benactyzine (an anticholinergic). Further, the structure is similar to methadone and related compounds like dextropropoxyphene
.

It was invented in Germany in the 1950s,

In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9617 and a 2013 annual aggregate manufacturing quota of zero.

References

  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ^ GB 716700, Boehringer A, et al., "A new and improved analgesic and process for its production", published 10/13/1954 
  3. PMID 5232927
    .
  4. .
  5. .